Abstract Type I collagen is the major component of few specific metalloproteases. While type I collagen is many extracellular matrices, and its accumulation char-essential to provide mechanical strength to tissues, as acterizes most fibrotic processes. It is synthesized exemplified by osteogenesis imperfecta [2], its abnorby a small number of discrete cell types, including mal accumulation, along with other extracellular fibroblasts, osteoblasts and odontoblasts. Analysis of matrix proteins, is characteristic of fibrotic diseases transgenic mice harbouring different segments of the and is responsible for major dysfunctions of affected promoters of the mouse pro-a1(I ) and pro-a2(I ) genes organs. has led to the conclusion that this tissue-specific expresDespite the fact that type I collagen is present in sion is controlled by different cis-acting elements which most organs, it is synthesized only by a small number are responsible for the expression of type I collagen of discrete cell types, including fibroblasts, osteoblasts genes in different type I collagen-producing cells. Trans-and odontoblasts. Generation of transgenic mice acting factors which bind to these different tissue-harbouring various segments of the mouse pro-a1(I ) specific elements are still unknown, but they probably collagen or pro-a2(I ) collagen promoter, cloned act by modifying the chromatin structure. In fibroblas-upstream of different reporter genes, has shown that, tic cells, various soluble molecules can modulate the within these promoters, there is a modular arrangement transcription of type I collagen genes. Analysis of the of different cis-acting elements which are responsible pro-a1(I ) and pro-a2(I ) proximal promoters has led for the expression of reporter genes in different type I to the identification of different cis-acting elements collagen-producing cells [3, 4] . For example, if one which can modulate the expression of reporter genes, considers the pro-a1(I ) collagen gene (Figure 1) , an in transfection experiments. Among these cis-acting element located within 800 bp of the proximal proelements, a sequence located between −378 and moter, induced an expression of reporter genes spe-−183 bp in the human pro-a2(I ) promoter appears to cifically in some skin fibroblasts. Another element mediate the transcriptional effects of transforming located~1.7 kb upstream of the transcription start growth factor-b. It binds a large multimeric complex site induced high levels of expression of the lacZ and which contains Sp1, as well as AP1 and other DNA-luciferase reporter genes in osteoblasts and odontobbinding proteins which have not yet been identified.
Regulation of type I collagen gene expression 67 Fig. 1 . Schematic representation of the modular arrangement of different regulatory domains identified in the mouse pro-a1(I ) collagen promoter. We postulate that other regulatory domains remain to be identified. E1, exon 1; E2, exon 2. selectively in osteoblastic cell lines. A second sub-factors (reviewed in [14] ). Nevertheless, it should be stressed that TGF-b can modify not only the transcripsegment was required for the expression of the lacZ reporter gene at high levels. A third one seemed to be tion rate of type I collagen genes but also the stability of the corresponding mRNAs, the relative contribution responsible for preventing promiscuous expression of the reporter gene. Trans-acting factors binding to the of these two mechanisms depending on cell types and on culture conditions [15] . Other factors such as different tissue-specific cis-acting elements are still unknown, but results derived from transfection experi-tumour necrosis factor-a ( TNF-a), interferon-c (IFN-c), IL-10, prostaglandin E2 or corticosteroids ments (J. Rossert et al., unpublished results), from analyses of DNase I hypersensitive sites [4] , and from inhibit type I collagen production by fibroblastic cells (reviewed in [10] ). With the possible exception of IFNin vivo footprinting experiments [9] suggest that they act by modifying the chromatin structure.
c, these factors act mostly on the transcription of type I collagen genes. If one focuses on the human proIn vitro experiments using type I collagen-producing cells have shown that different soluble molecules can a2(I ) collagen promoter, results of transfection experiments suggest that TNF-a acts through the same cismodulate type I collagen synthesis. In particular, cytokines including interleukin-1 (IL-1) and IL-4, growth acting elements that mediate the effects of TGF-b [16 ] .
Gel shift experiments have suggested that TNF-a could factors such as transforming growth factor-b ( TGFb) and insulin-like growth factor-1 (IGF-1), vasoactive act by modifying the TGF-b-targeted transcription complex and/or by increasing the binding of a represspeptides such as endothelin-1, or other molecules such as lipid peroxidation products can stimulate type I ive factor to the TGF-b-responsive element [16 ] .
Transfection experiments performed using the mouse collagen production by fibroblastic cells (reviewed in [10] ). Among all these factors, TGF-b has been the pro-a2(I ) proximal promoter have shown that sequences located between −2048 and −981 bp and most extensively studied, and its ability to stimulate fibroblast proliferation, to increase collagen production between −506 and −351 bp are important for corticosteroid-mediated inhibition of transcription, but the and to inhibit collagen degradation has been shown by many groups. Analysis of the mouse and human cis-acting elements responsible for this inhibition have not yet been identified [17] . We have also recently pro-a2(I ) proximal promoter using transfection experiments has led to the identification of a so-called 'TGF-identified a strong cis-acting inhibitory element within the pro-a1(I ) promoter, which strongly decreases the b-responsive element' located between −378 and Another study has suggested that an AP-1-binding site located between −265 and −241 bp is also critical for
